Journal of Affective Disorders
Volume 105, Issue 1 , Pages 117-124 , January 2008

First-episode psychosis: An epidemiological survey comparing psychotic depression with schizophrenia

  • Kathleen Crebbin

      Affiliations

    • Northumberland, Tyne and Wear NHS Trust, United Kingdom
    • ,
  • Emma Mitford

      Affiliations

    • Northumberland, Tyne and Wear NHS Trust, United Kingdom
    • Corresponding Author InformationCorresponding author. Emma Mitford is to be contacted at PACE Project, Northumberland, Tyne and Wear Mental Health NHS Trust St George's Park, Morpeth, Northumberland, NE61 2NU, United Kingdom. Tel.: +44 1670 501 788; fax: +44 1670 501 893.
    • ,
  • Roger Paxton

      Affiliations

    • Northumberland, Tyne and Wear NHS Trust, United Kingdom
    • Newcastle University, United Kingdom
    • ,
  • Douglas Turkington

      Affiliations

    • Northumberland, Tyne and Wear NHS Trust, United Kingdom

Received 24 January 2007 ,Revised 25 April 2007 ,Accepted 25 April 2007.

References 

  1. Akiskal HS, Walker P, Puzantian VR, King D, et al. Bipolar outcome in the course of depressive illness: phenomenologic, familial, and pharmacologic predictors. J. Affect. Disord. 1983;5:115–128
  2. Baldwin P, Browne D, Scully PJ, Quinn JF, et al. Epidemiology of first episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years. Schizophr. Bull. 2005;31(3):624–639
  3. Birkenhager TK, Van Den Broek WW, Mulder PGH, de Lely A. One-year outcome of psychotic depression after successful electroconvulsive therapy. J. ECT. 2005;21:221–226
  4. Charlton B, Taylor PRA, Proctor SJ. The PACE strategy: a new approach to multicentre clinical research. Q. J. Med. 1997;90:147–151
  5. Coryell W, Pfohl B, Zimmerman M. The clinical and neuroendrocrine features of psychotic depression. J. Nerv. Ment. Dis. 1984;172(9):521–528
  6. Coryell W, Leon A, Winokur G, Endicott J, et al. Importance of psychotic features to long-term course in major depressive disorder. Am. J. Psychiatry. 1996;153(4):483–490
  7. Coryell W. The treatment of psychotic depression. J. Clin Psychiatry. 1998;59:22–28
  8. Craig TJ, Bromet EJ, Jandorf L, Fennig S, et al. Diagnosis, treatment, and six-month outcome status in first-admission psychosis. Ann. Clin. Psychiatry. 1997;9(2):89–96
  9. Dannon PKN, Lowengrub K, Gonopolski Y, Kotler M. Current and emerging somatic treatment strategies in psychotic major depression. Expert Rev. Neurother. 2006;6(1):73–80
  10. Gladstone GL, Parker GB, Mitchell PB, Malhi GS, et al. Implications of childhood trauma for depressed women: an analysis of pathways from childhood sexual abuse to deliberate self-harm and revictimization. Am. J. Psychiatry. 2004;161:1417–1425
  11. Guest JF, Cookson RF. Cost of schizophrenia to UK society. An incidence-based cost-of-illness model for the first 5 years following diagnosis. Pharmacoeconomics. 1999;15:597–610
  12. Hall RC, Wise MG. The clinical and financial burden of mood disorders. Cost and outcome. Psychosom. 1995;36(2):S11–S18
  13. Johnson J, Howarth E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch. Gen. Psychiatry. 1991;45(12):1075–1081
  14. Johnstone P, Zolese G. Systematic review of the effectiveness of planned short hospital stays for mental health care. BMJ. 1999;318:1387–1390
  15. Kroessler D. Relative efficacy rates for therapies of delusional depression. Convuls. Ther. 1985;1:173–182
  16. Lattuada E, Serretti A, Cusin C, Gasperini M, Smeraldi E. Symptomatologic analysis of psychotic and non-psychotic depression. J. Affect. Disord. 1999;54(1–2):183–187
  17. Lauber C, Lay B, Rossler W. Length of first admission and treatment outcome in patients with unipolar depression. J. Affect. Disord. 2006;93:43–51
  18. Mental Health Strategies . The 2004/05 National Survey of Investment in Mental Health Services. Department of Health; 2005;
  19. Mitchell AJ, Malone D. Physical health and schizophrenia. Curr. Opin. Psychiatry. 2006;19:432–437
  20. National Institute for Health and Clinical Excellence . Technology appraisal 59. Guidance on the Use of Electroconvulsive Therapy. London: HMSO; 2003;
  21. National Institute for Health and Clinical Excellence . Clinical guideline 23. Depression Management of Depression in Primary and Secondary Care. London: HMSO; 2004;
  22. National Institute for Mental Health in England . Making it Possible: Improving Mental Health and Well-Being in England. NIMHE; 2005;
  23. O'Connor MK, Knapp R, Hussain M, et al. The influence of age on the response of major depression to electroconvulsive therapy: a CORE report. Am. J. Geriatr. Psychiatry. 2001;9(4):382–390
  24. Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am. J. Psychiatry. 2002;159(11):1855–1861
  25. Oquendo M, Brent DA, Birmaher B, et al. Posttraumatic stress disorder comorbid with major depression: factors mediating the association with suicidal behaviour. Am. J. Psychiatry. 2005;162:560–566
  26. Parker G, Roy K, Hadzi-Pavlovic D, Pedic F. Psychotic (delusional) depression: a meta-analysis of physical treatments. J. Affect. Disord. 1992;24(1):17–24
  27. Petrides G, Fink M, Husain MM, Knapp RG, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J. ECT. 2001;17(4):244–253
  28. Proctor SJ. The use of population-based research approaches in haematological malignancy: a general medical research tool. In:  Amiel S editors. Horizons in Medicine: Number 13. 1st edn.. London: Royal College of Physicians; 2002;p. 219–226
  29. Proctor SJ, Taylor PRA. A practical guide to continuous population based data collection (PACE): a process facilitating uniformity of care and research into practice. Quart. J. Med. 2000;93:67–73
  30. Proctor SE, Mitford E, Paxton R. First episode psychosis: a novel methodology reveals higher than expected incidence; a reality-based population profile in Northumberland, UK. J. Eval. Clin. Pract. 2004;10(4):539–547
  31. Rothschild AJ. Challenges in the treatment of depression with psychotic features. Biol. Psychiatry. 2003;53(8):680–690
  32. Rothschild AJ, Duval S. How long should patients with psychotic depression stay on the antipsychotic medication?. J. Clin. Psychiatry. 2003;64:390–396
  33. Rothschild AJ, Mulsant BH, Meyers BS, Flint AJ. Challenges in differentiating and diagnosing psychotic depression. Psychiatr. Ann. 2006;36(1):40–47
  34. Santhouse A, Holloway F. Physical health of patients in continuing care. Adv. Psychiatr. Treat. 1999;5:455–462
  35. Schatzberg AF. New approaches to managing psychotic depression. J. Clin. Psychiatry. 2003;64(1):19–23
  36. Simpson S, Baldwin RC, Jackson A, Burns A. The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features. Biol. Psychiatry. 1999;45(2):193–204
  37. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. In: Psychiatric Morbidity among Adults Living in Private Households. National Statistics. vol. 154:London: The Stationery Office; 2000;
  38. Skegg K. Self-harm. Lancet. 2005;366(9495):1471–1484(Oct22–Oct28)
  39. Strober M, Carlson G. Bipolar illness in adolescents with major depression. Arch. Gen. Psychiatry. 1982;39:549–555
  40. Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, et al. A national study of violent behavior in persons with schizophrenia. Arch. Gen. Psychiatry. 2006;63:490–499
  41. Symonds CS, Taylor S, Tippins V, Turkington D. Violent self-harm in schizophrenia. Suicide Life-threat. Behav. 2006;36(1):44–49
  42. Taylor D, Kerwin R, Paton C. The Maudsley 2005 Prescribing Guidelines. 8th ed.. London: Taylor & Francis; 2005;
  43. Thakur M, Hays J, Ranga K, Krishnan R. Clinical, demographic and social characteristics of psychotic depression. Psychiatry Res. 1999;86:99–106
  44. Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am. J. Psychiatry. 1993;150(8):1182–1188
  45. Vythilingam M, Chen J, Bremner JD, Mazure CM, et al. Psychotic depression and mortality. Am. J. Psychiatry. 2003;160(3):574–577
  46. Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA. Pharmacological treatment for psychotic depression. Cochrane Database Syst. Rev. 2005;4:Art No.: CD004044

PII: S0165-0327(07)00170-X

doi: 10.1016/j.jad.2007.04.025

Journal of Affective Disorders
Volume 105, Issue 1 , Pages 117-124 , January 2008

Article Tools